COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2
- 12 August 1989
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 334 (8659) , 395
- https://doi.org/10.1016/s0140-6736(89)90577-1
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsisThe American Journal of Medicine, 1989
- Interleukin-2 Administration Causes Reversible Hemodynamic Changes and Left Ventricular Dysfunction Similar to Those Seen in Septic ShockChest, 1988
- New Approaches to the Immunotherapy of Cancer Using Interleukin-2Annals of Internal Medicine, 1988
- Structure and function of the anaphylatoxinsSpringer Seminars in Immunopathology, 1984